Table 5 The CVDs target information.
Gene_Name | Protein Name | Degree |
---|---|---|
ADCY5 | Adenylate cyclase type V | 47 |
CYP2A5 | Cytochrome P450 2A5 | 35 |
NR3C2 | Glucocorticoid receptor | 20 |
HTR2A | 5-hydroxytryptamine receptor 2A | 18 |
ESR1 | Estrogen Receptor | 18 |
ALDH2 | Aldehyde dehydrogenase | 15 |
CYP1A1 | Cytochrome P450 1A1 | 13 |
NR3C1 | Glucocorticoid receptor | 12 |
PDE2A | Phosphodiesterase 2A | 12 |
VDR | Vitamin D receptor | 9 |
AKR1B1 | Aldose reductase | 9 |
AR | Androgen Receptor | 8 |
ALOX5 | 5-Lipoxygenase | 8 |
G6PD | glucose-6-phosphate 1-dehydrogenase isoform b | 8 |
PLA2G2A | Phospholipase A2 group IIA | 8 |
RARA | Retinoic acid receptor alpha | 8 |
CYP2A6 | Cytochrome P450 2A6 | 7 |
MTNR1A | Melatonin receptor 1A | 5 |
ALOX12 | Arachidonate 12-lipoxygenase | 4 |
GLO1 | Glyoxalase I | 4 |
ACHE | Acetylcholinesterase | 3 |
HTR5A | Serotonin 5a receptor | 3 |
LTA4H | Leukotriene A4 Hydrolase | 3 |
SLC6A4 | Serotonin Transporter | 3 |
RELA | v-rel reticuloendotheliosis viral oncogene homolog A isoform 1 | 3 |
ADORA1 | Adenosine A1 receptor | 3 |
ALOX5 | 5-Lipoxygenase | 2 |
PLK2 | Polo-Like Kinase 2 | 2 |
TSPO | Translocator protein | 2 |
NOX4 | NADPH oxidase 4 | 2 |
GPR35 | G protein-coupled receptor 35 | 2 |
ADORA2A | Adenosine Receptor A2A | 2 |
MMP9 | Matrix metalloproteinase 9 | 2 |
ADORA3 | Adenosine receptor A3 | 2 |
ADRA2B | Alpha-2b adrenergic receptor | 2 |
MMP3 | Matrix metalloproteinase-3 | 2 |
FABP4 | Fatty acid binding protein adipocyte | 1 |
SFRP1 | Secreted frizzled-related protein 1 | 1 |
PLA2G1B | Phospholipase A2 | 1 |
AVPR2 | Vasopressin V2 Receptor | 1 |
CXCR1 | Interleukin-8 receptor A | 1 |
MPO | Myeloperoxidase | 1 |
SORD | Sorbitol dehydrogenase | 1 |
F7 | Coagulation factor III/VII | 1 |
PARP1 | Poly [ADP-ribose] polymerase-1 | 1 |
ADRB1 | Beta-1 adrenergic receptor | 1 |